Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | ME1 |
| Upstream (Parents) |
|---|
| (<<) ADCY9 → ME1 |
| (<<) ATP2C2 → ME1 |
| (<<) ATP7B → ME1 |
| (<<) EPHB3 → ME1 |
| (<<) FGFR3 → ME1 |
| (<<) FZD1 → ME1 |
| (<<) GLRX → ME1 |
| (<<) HLA-G → ME1 |
| (<<) KLF11 → ME1 |
| (<<) LTA4H → ME1 |
| (<<) MYL5 → ME1 |
| (<<) NFATC1 → ME1 |
| (<<) PALM → ME1 |
| (<<) PRKCZ → ME1 |
| (<<) PTPRE → ME1 |
| (<<) RAB15 → ME1 |
| (<<) SHB → ME1 |
| (<<) SLC5A1 → ME1 |
| (<<) SPAG5 → ME1 |
| (<<) TUBA1A → ME1 |
| (<<) YWHAQ → ME1 |
| Downstream (Children) |
|---|
| ME1 → CDC42EP2 (>>) |
| ME1 → FZD2 (>>) |
| ME1 → GALR3 (>>) |
| ME1 → GNE (>>) |
| ME1 → HSPA2 (>>) |
| ME1 → INVS (>>) |
| ME1 → SLC20A1 (>>) |
| ME1 → ZNF205 (>>) |
